Chargement en cours...

Health technology assessment of biosimilars worldwide: a scoping review

BACKGROUND: Health technology assessment (HTA) should provide an assessment of a technology’s effects on health and of the related social, economic, organisational and ethical issues. HTA reports on biosimilars can specifically assess their immunogenicity, their extrapolation to one or more conditio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Health Res Policy Syst
Auteurs principaux: Ascef, Bruna de Oliveira, Lopes, Ana Carolina de Freitas, de Soárez, Patrícia Coelho
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448328/
https://ncbi.nlm.nih.gov/pubmed/32843051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12961-020-00611-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!